B-cell linker
B-cell linker (BLNK), also known as SLP-65 (SH2 domain-containing leukocyte protein of 65 kDa) and BASH, is a crucial adaptor protein in B cells. It plays a significant role in B cell receptor (BCR) signaling, which is essential for B cell development, differentiation, and function. BLNK is encoded by the BLNK gene in humans.
Function
BLNK serves as a central platform for the assembly of a signaling complex following BCR engagement. Upon B cell receptor activation, BLNK is phosphorylated, creating docking sites for various signaling molecules. This phosphorylation allows the recruitment of phospholipase C gamma (PLCγ), Bruton's tyrosine kinase (Btk), and other signaling proteins, facilitating the propagation of the signal that leads to calcium mobilization, cell proliferation, and antibody production.
Structure
The structure of BLNK comprises several domains, including an N-terminal leucine-rich repeat (LRR) domain, a central Src homology 2 (SH2) domain, and a C-terminal proline-rich region. The SH2 domain is critical for the interaction with phosphorylated tyrosine residues on the BCR and other proteins, while the proline-rich region provides docking sites for SH3 domain-containing proteins.
Clinical Significance
Mutations or deficiencies in BLNK can lead to immunodeficiency disorders. Patients with BLNK mutations often exhibit reduced numbers of mature B cells and impaired antibody responses, leading to increased susceptibility to infections. This highlights the importance of BLNK in the immune response and its potential as a target for therapeutic intervention in immune disorders.
Research and Therapeutic Potential
Research into BLNK has provided insights into the molecular mechanisms underlying B cell activation and the immune response. Targeting BLNK or its signaling pathway components offers potential therapeutic strategies for autoimmune diseases, immunodeficiencies, and certain types of cancer where B cells play a critical role.
This article is a molecular biology stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD